Genfleet Therapeutics (Shanghai), Inc. Class H
Important Dates
Genfleet Therapeutics (Shanghai), Inc. Class H's next confirmed earnings release is scheduled for March 24, 2027.
| Earnings Date | 3/24/2027 |
Share Statistics
As of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H has 370.37M shares outstanding.
| Shares Outstanding | 370.37M |
Financial Position
As of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H maintains a current ratio of 5.85, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.85 |
| Quick Ratio | 5.61 |
| Debt / Equity | 5.56 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 102.00 |
Balance Sheet
EURAs of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H holds 252.52M in cash and equivalents against 12.28M in total debt, resulting in a net debt position of -135.53M. Total book value stands at 220.86M, with working capital of 218.11M providing operational flexibility.
| Cash & Cash Equivalents | 252.52M |
| Total Debt | 12.28M |
| Net Debt | -135.53M |
| Equity (Book Value) | 220.86M |
| Book Value Per Share | 0.60 |
| Working Capital | 218.11M |